Gen9, Arzeda Ink Supply Agreement for Synthetic DNA | GenomeWeb

NEW YORK (GenomeWeb) – Synthetic DNA fabricator Gen9 and chemical manufacturer Arzeda have announced a supply agreement.

Under the terms of the agreement, Gen9 will supply Arzeda with megabase quantities of synthetic DNA for use in its designer cell factories capable of industrial-scale chemical production.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.